National Health Investors (NYSE:NHI – Get Rating) issued an update on its FY 2022 earnings guidance on Tuesday morning. The company provided EPS guidance of $3.86-$3.92 for the period. The company issued revenue guidance of -.
National Health Investors Stock Performance
Shares of NYSE:NHI traded up $0.53 during midday trading on Tuesday, hitting $64.44. The stock had a trading volume of 3,760 shares, compared to its average volume of 186,322. The company has a market capitalization of $2.95 billion, a PE ratio of 35.02 and a beta of 0.88. The stock has a 50 day moving average price of $61.18 and a two-hundred day moving average price of $57.66. The company has a current ratio of 23.40, a quick ratio of 23.40 and a debt-to-equity ratio of 0.84. National Health Investors has a 1 year low of $50.22 and a 1 year high of $66.63.
National Health Investors (NYSE:NHI – Get Rating) last released its quarterly earnings data on Monday, May 9th. The real estate investment trust reported $0.18 EPS for the quarter, missing analysts’ consensus estimates of $0.63 by ($0.45). National Health Investors had a return on equity of 5.55% and a net margin of 29.35%. The company had revenue of $71.33 million for the quarter, compared to analysts’ expectations of $73.06 million. During the same period in the prior year, the firm posted $1.24 EPS. The firm’s quarterly revenue was down 11.8% on a year-over-year basis. As a group, equities analysts predict that National Health Investors will post 4.5 earnings per share for the current fiscal year.
Analyst Ratings Changes
Ad Tradewins
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.
And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Several equities analysts recently issued reports on NHI shares. BMO Capital Markets cut National Health Investors from an outperform rating to a market perform rating and set a $62.00 price objective for the company. in a report on Tuesday, June 21st. Credit Suisse Group began coverage on shares of National Health Investors in a research note on Wednesday, June 22nd. They issued an underperform rating on the stock. Finally, Capital One Financial assumed coverage on shares of National Health Investors in a report on Friday, June 3rd. They issued an overweight rating and a $64.00 price target on the stock. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of Hold and a consensus price target of $60.25.
Hedge Funds Weigh In On National Health Investors
Several institutional investors and hedge funds have recently modified their holdings of NHI. Raymond James & Associates lifted its stake in shares of National Health Investors by 7.0% during the first quarter. Raymond James & Associates now owns 21,335 shares of the real estate investment trust’s stock valued at $1,259,000 after buying an additional 1,403 shares during the period. Raymond James Financial Services Advisors Inc. lifted its stake in shares of National Health Investors by 5.7% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 6,806 shares of the real estate investment trust’s stock valued at $402,000 after buying an additional 368 shares during the period. PNC Financial Services Group Inc. lifted its stake in shares of National Health Investors by 29.2% during the first quarter. PNC Financial Services Group Inc. now owns 5,092 shares of the real estate investment trust’s stock valued at $300,000 after buying an additional 1,150 shares during the period. MetLife Investment Management LLC increased its position in National Health Investors by 53.0% during the first quarter. MetLife Investment Management LLC now owns 22,969 shares of the real estate investment trust’s stock worth $1,355,000 after purchasing an additional 7,957 shares during the last quarter. Finally, Panagora Asset Management Inc. acquired a new position in National Health Investors during the first quarter worth approximately $1,752,000. Hedge funds and other institutional investors own 63.53% of the company’s stock.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider National Health Investors, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and National Health Investors wasn’t on the list.
While National Health Investors currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source: marketbeat.com
